Review found differences in estimated treatments for chlamydia and gonorrhea despite CDC guidelines

Published Date: 02 Mar 2023

A review of chlamydia and gonorrhea prevention studies conducted by the Regenstrief Institute found that rates of presumptive treatment (antibiotics before diagnosis) varied.

Read Full News

Latest News

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

Pneumocystis pneumonia is striking unexpected patient groups, study shows

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia confirms 3 Marburg virus deaths in new outbreak

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Keto diet stops a young girl's epileptic seizures

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

High disease burden found among at-risk Medicaid beneficiaries

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Trial evaluates a vitamin B3 derivative in people with long COVID

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Latest News

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

News All Time

Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

Monoclonal antibodies effectively prevent respiratory syncytial virus in infants

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six months of age or people ...

Preliminary case of bird flu in Washington state would be U.S.'s first in 9 months

Health officials in Washington state say they have identified the nation's first human case of bird flu since February, pending confirmatory testing.

Overlooked layer of DNA may explain disease risk, severity

Scientists at The Hospital for Sick Children (SickKids) have revealed a previously overlooked layer of genetic variation that could help explain why people experience disease differently, and why some treatments work better ...

Reversing fibrosis: New research provides insight for novel therapies

Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease.

Ethiopia confirms first Marburg outbreak as WHO lauds country's fast action

Ethiopia on Friday confirmed its first Marburg outbreak after nine cases were identified in a southern region of the country that borders South Sudan.

Metabolic hormone found to boost resilience against flu symptoms

A hormone known for regulating energy balance also helps the body cope with influenza by triggering protective responses in the brain, a study led by UT Southwestern Medical Center researchers shows.

Measles case confirmed in southwestern Colorado, possible exposures in Cortez, Mancos

People in Cortez and Mancos may have been exposed to the measles from a confirmed case in a school-aged child in Montezuma County, according to the Colorado Department of Public Health and Environment.

Typhoid conjugate vaccine demonstrates strong safety and immunogenicity in Phase III trial

Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa. EuTYPH-C Inj. Multi-dose ...

First death linked to 'meat allergy' spread by ticks

University of Virginia School of Medicine researchers have identified the first death caused by what is commonly called the "meat allergy" being spread by ticks.

Testing lung function earlier may help identify risk for COPD

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study published in the September ...

Ethiopia investigates possible outbreak of new viral hemorrhagic fever after 8 people are infected

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

COP30 report reveals how climate change is spreading infectious diseases to new regions

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Headaches affect almost a third of people worldwide

Do you have regular migraine headaches? If so, you've got a lot of company.

Stinky socks help replace human bait in surveys for river blindness

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Q&A: Why experts urge continued hepatitis B vaccine birth doses for newborns

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

Recommended News For You

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

Clinical trial is testing whether heavy lifting could combat cancer side effects

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

Researchers study effects of cannabis on sedation, cancer treatment symptoms

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria

Recommended Articles For You

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients 

The Latest Research on Wiskott Aldrich Syndrome  

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

2.

New CAR T-Cell Therapy Approved for Leukemia

3.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

4.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

5.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

1.

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care

2.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

3.

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine

4.

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target

5.

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

2.

Thromboprophylaxis In Medical Settings

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot